It is just after 11 a.m. in Seattle on Thursday, July 26 2007. Here are the issues turning heads in the LexBlogosphere today:
- Utah lawyer Glen Neeley at the Utah DUI Trial Lawyer Blog provides commentary on an article that highlights ramifications of driving under the influence of prescription drugs.
- At Regan Zambri & Long’s DC Metro Area Medical Malpractice Law Blog, the firm’s blogging lawyers highlight a recent study illustrating differences between first and second generation diabetes medications.
- In the New York Attorney Malpractice Blog, New York lawyer Andrew Lavoott Bluestone comments on a “shocking” medical malpractice case recently won by a California attorney.
- Ryan Esler at the Corvette Blog provides Corvette buffs with the latest on production constraints for 2008 models of Chevrolet’s classic American sports car.
- The FDA’s Nanotechnology Task Force recently released their nanotechnology report, and Lynn Bergeson of Bergeson & Campbell P.C. was quick to begin reporting. Today, she opens the day with a brief rundown of the recommendations outlined by the Task Force.